Heat Biologics, Inc. Reports 2014 Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- L3Harris CEO steps down amid conduct review, shares drop
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Heat Biologics (HTBX) Posts Q3 Loss of 46c/Share
November 14, 2014 8:10 AM ESTHeat Biologics (NASDAQ: HTBX) reported Q3 EPS of ($0.46), $0.04 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Heat Biologics (HTBX) click here.
... More